FUNDRAISING & CORPORATE DEVELOPMENT
We turn development logic into a financeable proposition and connect it to the right capital pathway.
THE INVESTABILITY QUESTION
A defined milestone that creates measurable
value and derisks the next stage.
Right-sized plan and use of proceeds to reach
the next value inflection.
Positioned for investors aligned with the asset,
stage and geography.
OUR CAPITAL INTRODUCTION PATHWAY
Assess science, data,
plan and financing gaps.
Refine strategy, plan
and milestones.
Craft the investment story
and value narrative.
Target the right
investors, partners
and channels.
Support diligence,
negotiation and
term sheet.
Enable a successful close
and continued support.
INTEGRATED MODEL
Independent expertise. Strategic matching. A stronger execution.
Founder & CEO, BioBrokers
Capital Markets & Strategic Transactions
Valeriia advises companies on fundraising, M&A, licensing and strategic transactions across international markets. Her scientific background spans neuroscience, psychiatry, pharmacology and immuno-oncology.
Capital introduction is undertaken through the specialist transaction partner. MB & Partners does not present itself as a securities broker or placement agent.
We combine deep capital markets and strategic transaction expertise with integrated medical, regulatory and commercial development experience to connect innovative companies with the right investors and partners.
WHAT WE OFTEN CHANGE FIRST
From broad aspirations to a
defined, investable milestone.
From wishful plans to right-sized,
capital-efficient development.
From technical detail to a clear,
compelling investment case.
From gaps and uncertainty to
targeted data generation.
From diffuse spending to
value-driving, de-risking milestones.
NEXT DISCUSSION
Copyright © 2026 Manolo Beelke & Partners. All rights reserved.
